Analytical Validity and Clinical Utility of Tumor Biomarkers

To the Editor In his recent editorial, Dr Hayes correctly noted that "analytical validity and clinical utility" are needed for the adoption of a tumor biomarker test into clinical care. However, proving analytical validity with correlative or concordance studies is largely irrelevant without first proving clinical utility.

https://ift.tt/2L4UX1A